U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H14N5O4P
Molecular Weight 287.2123
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TENOFOVIR ANHYDROUS

SMILES

C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O

InChI

InChIKey=SGOIRFVFHAKUTI-ZCFIWIBFSA-N
InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/20439609 and http://ir.chimerix.com/releasedetail.cfm?releaseid=752310

CMX157 is a lipid (1-0-hexadecyloxypropyl) conjugate of the acyclic nucleotide analog tenofovir (TFV) with activity against both wild-type and antiretroviral drug-resistant HIV strains, including multidrug nucleoside/nucleotide analog-resistant viruses. CMX157 was designed to mimic lysophosphatidylcholine to take advantage of natural lipid uptake pathways and to achieve high intracellular concentrations of the active antiviral, with the aim of increasing the effectiveness of TFV against wild-type and mutant HIV. CMX157 demonstrated potential to effectively suppress replication of multiNRTI-resistant (MNR) HIV that cannot be treated with any currently available NRTIs, including TDF. It is in phase II clinical trial for HIV infections in USA and phase Ib portion of the phase I/II trial for Hepatitis B in Thailand (PO).

Originator

Curator's Comment: reference retrieved from http://www.sciencedirect.com/science/article/pii/S2211383512001402

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
58.0 µM [Kd]
3.3 nM [EC50]
3.5 nM [EC50]
0.49 µM [EC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
VIREAD

Approved Use

Tenofovir disoproxil fumarate is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV and HBV infections

Launch Date

1.32675836E12
Primary
VIREAD

Approved Use

Tenofovir disoproxil fumarate is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV and HBV infections

Launch Date

1.32675836E12
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

The recommended dose of Ictady (tenofovir disoproxil succinate) for the treatment of HIV or for the treatment of chronic hepatitis B is 245 mg (one tablet) once daily taken orally with food.
Route of Administration: Oral
In Vitro Use Guide
(R)-9-(2-Phosphonylmethoxypropyl)adenine (PMPA known as tenofovir) exerts antiretrovirus activity in MT-4 cells infected with HIV-1 and HIV-2 with EC50 values of 5.9 and 4.9 uM, respectively
Name Type Language
TENOFOVIR ANHYDROUS
Common Name English
tenofovir [INN]
Common Name English
TENOFOVIR [MI]
Common Name English
Tenofovir [WHO-DD]
Common Name English
GS-1275
Code English
PHOSPHONIC ACID, P-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)-
Systematic Name English
(R)-9-(2-PHOSPHONOMETHOXYPROPYL)ADENINE
Systematic Name English
Classification Tree Code System Code
NDF-RT N0000175459
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
NDF-RT N0000175656
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
NDF-RT N0000009947
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
NDF-RT N0000175462
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
NDF-RT N0000175459
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
NDF-RT N0000175459
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
Code System Code Type Description
WIKIPEDIA
Microbicides for sexually transmitted diseases
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY
MERCK INDEX
m10559
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY Merck Index
PUBCHEM
464205
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY
EPA CompTox
DTXSID9040132
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY
INN
7913
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY
SMS_ID
100000085232
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY
RXCUI
1546017
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY RxNorm
EVMPD
SUB25192
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
ALTERNATIVE
NCI_THESAURUS
C170540
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY
FDA UNII
W4HFE001U5
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY
EVMPD
SUB04721MIG
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY
DRUG BANK
DB00300
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY
DAILYMED
W4HFE001U5
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY
CAS
147127-20-6
Created by admin on Fri Dec 15 15:49:09 UTC 2023 , Edited by admin on Fri Dec 15 15:49:09 UTC 2023
PRIMARY